Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 2:43 pm Purchase | 2025-06-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 5,762,349 9.900% | 1,681,261 (+41.20%) | Filing History |
| 2025-08-13 1:56 pm Sale | 2025-06-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,676 9.900% | -250,555 (-35.03%) | Filing History |
| 2025-08-12 11:40 am Sale | 2025-06-30 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 570,326 5.200% | -99,832 (-14.90%) | Filing History |
| 2025-08-11 5:04 pm Sale | 2025-06-30 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 0 0.000% | -343,781 (Position Closed) | Filing History |
| 2025-08-11 3:21 pm Purchase | 2025-06-30 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,359,046 9.900% | 80,000 (+1.10%) | Filing History |
| 2025-08-11 2:39 pm Unchanged | 2025-08-01 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 10,987,104 9.900% | 0 (Unchanged) | Filing History |
| 2025-08-11 1:57 pm Purchase | 2025-06-30 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 14,432,072 9.900% | 4,545,103 (+45.97%) | Filing History |
| 2025-08-11 11:32 am Unchanged | 2025-08-01 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 10,987,104 9.400% | 0 (Unchanged) | Filing History |
| 2025-08-11 11:20 am Purchase | 2025-03-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 10,987,104 9.400% | 1,273,933 (+13.12%) | Filing History |
| 2025-05-13 11:07 am Sale | 2025-03-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 9,886,969 9.900% | -75,680 (-0.76%) | Filing History |
| 2025-05-12 2:45 pm Sale | 2025-03-31 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 670,158 6.100% | -121,157 (-15.31%) | Filing History |
| 2025-05-12 2:12 pm Sale | 2025-03-31 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 343,781 2.500% | -620,806 (-64.36%) | Filing History |
| 2025-05-12 1:44 pm Sale | 2025-03-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 9,713,171 7.700% | -220,793 (-2.22%) | Filing History |
| 2025-05-12 1:29 pm Sale | 2025-03-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,279,046 9.900% | -295,284 (-3.90%) | Filing History |
| 2025-05-12 1:15 pm Purchase | 2025-05-05 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 6,674,993 9.900% | 15,000 (+0.23%) | Filing History |
| 2025-04-11 4:34 pm Purchase | 2025-03-31 | 13G | Talphera, Inc. TLPH | Rosalind Advisors Inc. | 7,642,515 9.900% | 7,642,515 (New Position) | Filing History |
| 2025-02-14 3:58 pm Sale | 2024-12-31 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 4,081,088 9.900% | -4,500 (-0.11%) | Filing History |
| 2025-02-13 1:41 pm Purchase | 2025-02-13 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 1,062,500 1.200% | 312,500 (+41.67%) | Filing History |
| 2025-02-13 12:50 pm Unchanged | 2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-12 11:29 am Purchase | 2024-12-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 9,962,649 9.900% | 2,765,873 (+38.43%) | Filing History |